<DOC>
	<DOCNO>NCT00157937</DOCNO>
	<brief_summary>Subjects 8-week montelukast sodium comparator drug administration period , 2-week wash-out period 8-week comparator drug drug administration period ( cross-over design ) assessment drug efficacy , safety tolerability .</brief_summary>
	<brief_title>A Study Compare Effectiveness Montelukast Sodium With Comparator Mild Moderate Persistent Asthmatics ( 0476-329 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Males female age 18 60 mild moderate asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>